Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Shares Outstanding (Weighted Average) (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.35% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, changed 0.35% year-over-year, with the annual reading at $2.0 billion for FY2025, 0.35% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $2.0 billion at Bristol Myers Squibb, roughly flat from $2.0 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $2.2 billion in Q1 2021, with the low at $2.0 billion in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $2.1 billion, with a median of $2.1 billion recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) decreased 4.22% in 2022, then grew 0.49% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $2.2 billion in 2021, then dropped by 4.1% to $2.1 billion in 2022, then decreased by 2.86% to $2.1 billion in 2023, then decreased by 2.03% to $2.0 billion in 2024, then rose by 0.35% to $2.0 billion in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $2.0 billion, $2.0 billion, and $2.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.